Table 1 Baseline characteristics of the patient population (N = 44)
Characteristic | Total (N = 44) |
|---|---|
Age, years | |
Median | 67 |
Range | 51–84 |
Gleason score available, n (%) | 39 (89) |
≤7 | 15 (38) |
>7 | 24 (62) |
PSA level at baseline, ng/mL | |
Median | 22.2 |
Range | 0.2–746 |
Extent of disease, n (%) | |
Local relapse | 6 (14) |
Locoregional | 1 (2) |
Metastases total | 36 (84) |
Peritoneum | 1 (2) |
Pelvis | 1 (2) |
Bladder | 1 (2) |
Lung | 3 (7) |
Liver | 1 (2) |
Lymph nodes | 26 (59) |
Bone | 28 (64) |
ECOG, n (%) | |
0 | 43 (98) |
1 | 1 (2) |
Time since diagnosis, weeks | |
Mean | 280.4 |
SD | 228.15 |
Previous therapy, n (%) | |
Prostatectomy | 23 (52) |
Radiotherapy | 28 (64) |
Hormone ablation | 44 (100) |